Диссертация (1139521), страница 53
Текст из файла (страница 53)
Oxidized low-density lipoprotein and atherosclerosis /D. Steinberg, J. L. Witztum // Arterioscler. Thromb. Vasc. Biol. – 2010. – Vol. 30, Iss.12. – P. 2311–2316.725. Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intrav enous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies / G. W. Albers [et al.] // Stroke. –2011. – Vol. 42. Iss. 9. – P. 2645–2650.726. Strokeinduced progenitor cell proliferation in adult spontaneously hypertensive rat brain: effect of exogenous IGF-1 and GDNF / R. Dempsey [et al.] //J. Neurochem.
– 2003. – Vol. 87, Iss. 3. – P. 586–597.727. Structural organization of the neutrophil NADFH-oxidase: phosphorilationand translocation during priming and activation / F. R. Sheppard [et al.] // J. Leukoc.Biol. – 2005. – Vol. 78, Iss. 5. – P. 1025–1042.728. Suarez, Е. С. Depressogenic vulnerability and gender- specific patterns ofneuro-immune dysregulation: What the ratio of cortisol to C-reactive protein can tell usabout loss of normal regulatory control / Е. С. Suarez, J. S. Sundy, A.
Erkanli // BrainBehav. and Immun. – 2015. – Vol. 44. – P. 137–147.729. Subcortical ischemic vascular dementia / G. C. Roman [et al.] // Lancet Neurology. – 2002. – Vol. 1, Iss. 7. – P. 426–436.730. Swirski, F. K. Leukocyte behavior in atherosclerosis, myocardial infacrtion,and heart failure / F. K. Swirski, M. Nahrendorf // Science. – 2013. – Vol. 339, N 6116.– P. 161–166.731. System x(c)- activity and astrocytes are necessary for interleukin-l{beta}mediated hypoxic neuronal injury / B. Fogal [et al.] // J. Neurosci. – 2007. – Vol. 27,Iss.
38. – P. 10094–10105.732. Systematic review on noninvasive assessment of subclinical cardiovasculardisease in obstructive sleep apnea: new kid on the block! / S. Ali [et al.] // Sleep Med.Rev. – 2014. – Vol. 18, Iss. 5. – P. 379–381.733. Systemic autoimmune diseases 2014 / G. Shi [et al.] // J. Immunol. Res. –2015. – Vol. 2015. – P. 183–591.317734. Systemic immune activation shapes stroke outcome / K. N. Murray [et al.] //Mol. Cell. Neurosci. – 2013.
– Vol. 53. – P. 14–25.735. T helper-cell phenotype regulates atherosclerosis in mice under conditions ofmild hypercholesterolemia / S.A. Huber [et al.] // Circulation. – 2001. – Vol. 103, Iss.21. – P. 2610–2616.736. T lymphocyte priming by neutrophil extracellular traps links innate andadaptive immune responses / K. Tillack [et al.] // J.
Immunol. – 2012. – Vol. 188, Iss. 7.– P. 3150–3159.737. Tanashyan, М. М. Chronic Cerebrovascular Disypeases on the Backgroundof Metabolic Syndrome: New Approaches to Treatment / М. М. Tanashyan, O. V.Lagoda, K. V. Antonova // Neurosci.
Behav. Physiol. – 2014. – Vol. 44, Iss. 2. –P. 163–168.738. Targeted mutation of Fas ligand gene attenuates brain inflammation in experimental stroke / F. Niua [et al.] // Brain. Behav. Immun. – 2012. – Vol. 26, Iss. 1. –P. 61–71.739. Targeting C-reactive protein for the treatment of cardiovascular disease /M. B. Pepys [et al.] // Nature.
– 2006. – Vol. 440, N 7088. – P. 1217–1221.740. Targeting TNF receptors in rheumatoid arthritis / S. Blüml [et al.] // Int.Immunol. – 2012. – Vol. 24, Iss. 5. – P. 275–281.741. Tecchio, C. Neutrophil-derived cytokines: facts beyond expression /C. Tecchio, A. Micheletti, M.
A. Cassatella // Front. Immunol. – 2014. – Vol. 5. – P.508.–Availableat:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204637/pdf/fimmu-05-00508.pdf742. Tergeting the neurovascular unit for treatment of neurological disorders /R. L. Vangilder [et al.] // Pharmacol. Ther. – 2011. – Vol. 130, Iss. 3. – P. 239–247.743. Terpolilli, N. A. Nitric oxide: considerations for the treatment of ischemicstroke / N. A. Terpolilli, M.
A. Moskowitz, N. Plesnila // J. Cereb. Blood Flow Metab. –2012. – Vol. 32, Iss. 7. – P. 1332–1346.318744. The chemokine system in diverse forms of macrophage activation and polarization / A. Mantovani [et al.] // Trends Immunol. – 2004. – Vol. 25, Iss. 12. – P. 677–686.745. The effect of folic acid based homocysteine lowering on cardiovascularevents in people with kidney disease: systematic review and meta-analysis /M. J. Jardine[etal.]//BMJ.–2012.–Vol.
344.–e3533.–doi:https://doi.org/10.1136/bmj.e3533746. The emerging role of biomarkers in atrial fibrillation / J. Komej [et al.] //Can. J. Cardiol. – 2013. – Vol. 29, Iss. 10. – P. 1181–1193.747. The hexosamine biosynthetic pathway couples growthfactor-induced glutamine uptake to glucose metabolism / K. E. Wellen [et al.] // Genes Dev. – 2010.
–Vol. 24, Iss. 24. – P. 2784–2799.748. The innate immune response during urinary tract infection and pyelonephritis / J. D. Spencer [et al.] // Pediatr. Nephrol. (Berlin, Germany). – 2014. – Vol. 29,Iss. 7. – Р. 1139–1149.749. The peptide analogue of MCP-1 65-67 seguence is an inhibitior of inflammation / E. I. Chazov [et al.] // Can. J. Physiol. Pharmacol. – 2007. – Vol. 85, Iss.
3–4. –P. 332–340.750. The prognostic impact of soluble apoptosis – stimulating fragment on mortality in patients with carotid atherosclerosis / M. Hoke [et al.] // Stroke. – 2011. –Vol.42, Iss. 9. – P. 2465–2470.751. The protective effect of alpha lipoic acid on Schwann cells exposed to constant or intermittent high glucose / L.
Sun [et al.] // Biochem. Pharmacol. – 2012. –Vol. 84, Iss. 7. – P. 961–973.752. The role of oxidative stress in adult critical care / Е. Crimi [et al.] // FreeRadic. Biol. Med. – 2006. – Vol. 40, Iss. 3. – P. 398–406.753. The S100B protein in biological fluids: more than a lifelong biomarker ofbrain distress / F. Michetti [et al.] // J. Neurochem. – 2012. – Vol. 120, Iss. 5. – P.
644–659.319754. The succinated proteome / E. Merkley [et al.] // Mass Spectrom. Rev. –2014. – Vol. 33, Iss. 2. – P. 98–109.755. The type 1 interleukin-1 receptor is essential for the efficient activation ofmicroglia and the induction of multiple proinflammatory mediators in response to braininjury / A. Basu [et al.] // J. Neurosci. – 2002. – Vol.
22, Iss. 14. – P. 6071–6082.756. The use of alpha-lipoic acid (ALA), gamma linolenic acid (GLA) and rehabilitation in the treatment of back pain: effect on health-related quality of life /M. Ranieri [et al.] // Int. J. Immunopathol.
Pharmacol. – 2009. – Vol. 22, 3 Suppl. – P.45–50.757. The World Alzheimer Report 2013. Journey of Caring: An analysis of longterm care for dementia. – URL: http://www.alz.co.uk/research/world-report-2013.758. Thundyil, J. DAMPs and neurodegeneration / J. Thundyil, K.-L. Lim // Ageing Res.
Rev. – 2015. – Vol. 24, (Pt A). – P. 17–28.759. Titze, J. Sodium sensing in the interstitium and relationship to hypertension /J. Titze, A. Machnic // Curr. Opin. Nephrol. Hypertens. – 2010. – Vol. 19, Iss. 4. – P.385–392.760. Titze, J. Taking another “look" at sodium / J. Titze, D.
N. Muller, F. C. Luft// Can. J. Cardiol. – 2014. – Vol. 30, Iss. 5. – P. 473–475.761. TNF receptor 1 signaling is critically in volved in mediating angiotensin-IIinduced cardiac fibrosis / C. Duerrschmid [et al.] // J. Mol. Cell. Cardiol. – 2013. – Vol.57. – P. 59–67.762. Tomomi, G. Nitric oxide and endoplasmic reticulum stress // Arterioscler.Thromb. Vasc. Biol. – 2006. – Vol. 26, Iss. 7. – P. 1439–1446.763.
Transforming growth factor-p regulation of proteoglycan synthesis in vascular smooth muscle: contribution to lipid binding an decelerated atherosclerosis in diabetes / S. N. Ymg [et al.] // J. Diabetes. – 2010. – Vol. 2, Iss. 4. – P. 233–242.764.
Tretter, L. Succinate, an intermediate in metabolism, signal transduction,ROS, hypoxia, and tumorigenesis / L. Tretter, A. Patocs, C. Chinopoulos // Biochim.Biophys. Acta. – 2016. – Vol. 1857, Iss. 8. – P. 1086–1101.320765. Unsuspected task for an old team: succinate, fumarate and other Krebs cycleacids in metabolic remodeling / P.
Benit [et al.] // Biochim. Biophys. Acta. – 2014. –Vol. 1837, Iss. 8. – P. 1330–1337.766. Vanderkaay, M. M. Nicotine and acute stress: effects of nicotine on stressinduced hemoconcentration / M. M. Vanderkaay, S. M. Patterson // Biol. Psychol. –2006. – Vol.
71, Iss. 2. – P. 191–201.767. Variants of the endothelial nitric oxide gene and cerebral blood flow aftersevere traumatic brain injury / C. S. Robertson [et al.] // J. Neurotrauma. – 2011. –Vol. 28, Iss. 5. – P. 727–737.768. Vascular cognitive impairment / J. T. O'Brien [et al.] // Lancet Neurol. –2003. – Vol. 2, Iss. 2. – P. 89–98.769. Vascular Contributions to Cognitive Impairment and Dementia: A statementfor healthcare professionals from the American Heart Association/American Stroke Association / P. B.
Gorelick [et al.] // Stroke. – 2011. – Vol. 42, Iss. 9. – P. 2672–2713.770. Vascular risk factors and longitudinal changes on brain MRI: the ARICstudy / D. S. Knopman [et al.] // Neurology. – 2011. – Vol. 76, Iss. 22. – P. 1879–1885.771. Vasoactive systems in L-NAME hypertension: the role of inducible metricoxide synthase / O. Pechanova [et al.] // J. Hypertens.
– 2004. – Vol. 22, Iss. 1. –P. 167–173.772. Verma, S. C-reactive protein comes of age / S. Verma, P. E. Szmitko,P. M. Ridker // Nat. Clin. Prac. Cardiovasc. Med. – 2005. – Vol. 2, Iss. 1. – Р. 29–36.773. Verro, P. Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis / P. Verro, P.
Gorelick, D. Nguyen //Stroke. – 2008. – Vol. 39, Iss. – 4. – P. 1358–1363.774. Vinpocetine inhibits NF-κB-dependent inflammation via an ikk-dependentbut pde-independent mechanism / K. I. Jeon [et al.] // Proc. Natl. Acad. Sci. USA. –2010. – Vol. 107, Iss. 21. – P. 9795–9800.775. Vinpocetine inhibits oligodendroglial precursor cell differentiation /K. J. Torres [et al.] // Cell. Physiol.
Biochem. – 2012. – Vol. 30, Iss. 3. – P. 711-722.321776. Vinpocetine reduces lipopolysaccharide-induced inflammatory pain andneutrophil recruitment in mice by targeting oxidative stress, cytokines and NF-κB / K.Ruiz-Miyazawa [et al.] // Chem. Biol. Interact. – 2015.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
